Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	28.85	61.58	9.24	20.99	55.89	63.83
Short-Term Investments	162.73	165.34	-	22.76	-	-
Cash & Short-Term Investments	191.58	226.92	9.24	43.76	55.89	63.83
Cash Growth	-34.59%	2356.33%	-78.89%	-21.71%	-12.44%	2568.39%
Accounts Receivable	0.23	0.12	1.17	1.36	1.61	2.01
Other Receivables	-	1.37	0.01	0	0.02	0.03
Receivables	0.23	1.48	1.18	7.47	1.63	2.05
Inventory	-	-	-	-	1.4	0.98
Prepaid Expenses	4.16	2.68	1.08	0.44	0.39	0.42
Other Current Assets	-	0.08	5.35	1.54	0.03	0.03
Total Current Assets	195.96	231.16	16.84	53.22	59.33	67.3
Property, Plant & Equipment	64.37	59.54	6.32	0.37	2.49	2.73
Long-Term Investments	-	0.13	0.13	0.15	-	-
Goodwill	-	-	24.06	-	-	-
Other Intangible Assets	50	50.01	50.35	0.03	0.11	0.13
Other Long-Term Assets	0.4	0.27	0.18	4.33	2.52	0.26
Total Assets	310.73	341.1	97.89	58.09	64.44	70.42
Accounts Payable	6.85	9.84	6.41	1.54	0.97	0.73
Accrued Expenses	5.04	5.48	3.59	1.3	1.03	0.82
Current Portion of Long-Term Debt	0.05	0.05	0.05	-	-	-
Current Portion of Leases	0.85	0.96	0.05	-	0.27	0.25
Current Unearned Revenue	-	1.4	-	-	-	-
Other Current Liabilities	0.2	0.5	5.57	0.28	-	-
Total Current Liabilities	12.99	18.23	15.66	3.12	2.27	1.8
Long-Term Debt	1.6	1.63	1.68	-	-	-
Long-Term Leases	1.07	1.43	0.78	-	0.26	0.52
Long-Term Unearned Revenue	26.6	26.6	-	-	-	-
Long-Term Deferred Tax Liabilities	2.5	2.5	4.59	-	-	-
Other Long-Term Liabilities	0.28	0.06	-	0.33	0.64	0.69
Total Liabilities	45.03	50.43	22.71	3.45	3.16	3.01
Common Stock	0.07	0.07	0.03	0.14	0.14	0.14
Additional Paid-In Capital	537	522.37	227.59	160.43	159.73	158.59
Retained Earnings	-271.38	-231.72	-152.44	-105.93	-98.6	-91.33
Comprehensive Income & Other	0	-0.05	-	-	-	-
Total Common Equity	265.69	290.67	75.18	54.64	61.28	67.41
Shareholders' Equity	265.69	290.67	75.18	54.64	61.28	67.41
Total Liabilities & Equity	310.73	341.1	97.89	58.09	64.44	70.42
Total Debt	3.57	4.06	2.55	-	0.52	0.78
Net Cash (Debt)	188.01	222.85	6.69	43.76	55.37	63.05
Net Cash Growth	-34.94%	3232.64%	-84.72%	-20.97%	-12.19%	4445.93%
Net Cash Per Share	2.61	3.46	0.25	3.08	3.90	6.07
Filing Date Shares Outstanding	74.26	74.05	58.69	28	14.21	14.19
Total Common Shares Outstanding	74.26	70.67	28.18	14.21	14.2	14.19
Working Capital	182.97	212.93	1.17	50.1	57.06	65.5
Book Value Per Share	3.58	4.11	2.67	3.84	4.31	4.75
Tangible Book Value	215.69	240.66	0.76	54.62	61.17	67.28
Tangible Book Value Per Share	2.90	3.41	0.03	3.84	4.31	4.74
Land	0.92	0.92	1.28	0.37	0.37	0.37
Buildings	1.77	1.77	1.77	-	-	-
Machinery	12.51	11.42	2.68	0.02	4.44	4.2
Leasehold Improvements	3.83	3.57	0.18	-	4.14	4.14

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q